Search Results - Freya Droege
- Showing 1 - 8 results of 8
-
1
-
2
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets by Stephan Lang, Kirsten Bruderek, Cordelia Kaspar, Benedikt Höing, Oliver Kanaan, Nina Dominas, Timon Hussain, Freya Droege, Christian Eyth, Boris Hadaschik, Sven Brandau
Published 2018Artigo -
3
<i>PDCD1</i> (<i>PD-1</i>) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients by Diane Goltz, Heidrun Gevensleben, Joern Dietrich, Friederike Schroeck, Luka de Vos, Freya Droege, Glen Kristiansen, Andreas Schroeck, Jennifer Landsberg, Friedrich Bootz, Dimo Dietrich
Published 2017Artigo -
4
European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT) by Claire L. Shovlin, Elisabetta Buscarini, Anette Drøhse Kjeldsen, Hans Jurgen Mager, Carlo Sabbà, Freya Droege, Urban W. Geisthoff, Sara Ugolini, Sophie Dupuis‐Girod
Published 2018Artigo -
5
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia by Claire L. Shovlin, Carolyn M. Millar, Freya Droege, Anette Drøhse Kjeldsen, Guido Manfredi, Patrizia Suppressa, Sara Ugolini, Nicole Coote, Annette Dam Fialla, Urban W. Geisthoff, Gennaro M. Lenato, Hans-Jurgen Mager, Fabio Pagella, Martijn C. Post, Carlo Sabbà, Ulrich Sure, Pernille Mathiesen Tørring, Sophie Dupuis‐Girod, Elisabetta Buscarini
Published 2019Artigo -
6
European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT) by Omer Eker, Edoardo Boccardi, Ulrich Sure, Maneesh C. Patel, Saverio Alicante, Ali Alsafi, Nicole Coote, Freya Droege, Olivier Dupuis, Annette Dam Fialla, Bryony A. Jones, Ujwal Kariholu, Anette Drøhse Kjeldsen, David Lefroy, Gennaro M. Lenato, Hans Jurgen Mager, Guido Manfredi, Troels Halfeld Nielsen, Fabio Pagella, Marco C. Post, Catherine Rennie, Carlo Sabbà, Patrizia Suppressa, Pernille Mathiesen Toerring, Sara Ugolini, Elisabetta Buscarini, Sophie Dupuis‐Girod, Claire L. Shovlin
Published 2020Artigo -
7
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care by Claire L. Shovlin, Elisabetta Buscarini, Carlo Sabbà, Hans Jurgen Mager, Anette Drøhse Kjeldsen, Fabio Pagella, Ulrich Sure, Sara Ugolini, Pernille Mathiesen Tørring, Patrizia Suppressa, Catherine Rennie, Martijn C. Post, Mitesh Patel, Troels Halfeld Nielsen, Guido Manfredi, Gennaro M. Lenato, David Lefroy, Ujwal Kariholu, Bryony A. Jones, Annette Dam Fialla, Omer Eker, Olivier Dupuis, Freya Droege, Nicole Coote, Edoardo Boccardi, Ali Alsafi, Saverio Alicante, Sophie Dupuis‐Girod
Published 2021Artigo -
8
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)? by Sophie Dupuis‐Girod, Claire L. Shovlin, Anette Drøhse Kjeldsen, Hans‐Jurgen Mager, Carlo Sabbà, Freya Droege, Anne‐Emmanuelle Fargeton, Annette Dam Fialla, S. Gandolfi, Ruben Hermann, Gennaro M. Lenato, Guido Manfredi, Marco C. Post, Catherine Rennie, Patrizia Suppressa, Ulrich Sure, Elisabetta Buscarini, Claudia Crocione, Ria Blom, Luisa M. Botella, Fernando Brocca, Caroline Coxall, Karen T. Druckman, Didier Erasme, Paolo Roberto Federici, Christina Grabowski, Mildred Lundgren, Tone Søderman, Dara Woods
Published 2022Artigo
Search Tools:
Related Subjects
Medicine
Biology
Pathology
Telangiectasia
Gene
Genetics
Internal medicine
Cancer
Cancer research
Dermatology
Human genetics
Pediatrics
Biochemistry
Biomarker
Disease
Head and neck cancer
Immunology
Oncology
Rare disease
Bevacizumab
Cell
Chemotherapy
Clinical significance
Cohort
Context (archaeology)
DNA methylation
Disease management
Family medicine
Gene expression
Head and neck squamous-cell carcinoma